Citation Impact
Citing Papers
Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin
2008
Highly Recurrent TERT Promoter Mutations in Human Melanoma
2013 StandoutScience
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
2017 Standout
The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency
2008 StandoutScienceNobel
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
Regulation of growth differentiation factor 15 expression by intracellular iron
2008 StandoutNobel
Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors
2010 StandoutNobel
Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features
2019
Accurate de novo design of heterochiral protein–protein interactions
2024 StandoutNobel
Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients
1986 StandoutNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer
2017
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Bone morphogenetic protein receptors and signal transduction
2009 Standout
TGFβ signalling in context
2012 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Functional Characterization of Bone Morphogenetic Protein Binding Sites and Smad1/5 Activation in Human Vascular Cells
2007
Immuno-Oncology: Emerging Targets and Combination Therapies
2018
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond
2018
Pro-protein convertases control the maturation and processing of the iron-regulatory protein, RGMc/hemojuvelin
2008
Repertoire of microglial and macrophage responses after spinal cord injury
2011 Standout
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Role of transforming growth factor-β superfamily signaling pathways in human disease
2008
Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site
2007
Evidence That Inhibition of Hemojuvelin Shedding in Response to Iron Is Mediated through Neogenin
2007
Interpretation of BMP signaling in early Xenopus development
2007 StandoutNobel
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
2018
Suppression of the hepcidin‐encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase‐2/TMPRSS6
2009 StandoutNobel
A mouse model of juvenile hemochromatosis
2005
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
2009
Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload
2005
Hypoxia inducible factor-1-dependent up-regulation of BMP4 mediates hypoxia-induced increase of TRPC expression in PASMCs
2015 StandoutNobel
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
2017
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
TGFβ in Cancer
2008 Standout
What We Talk About When We Talk About Fat
2014 Standout
Applications of machine learning in drug discovery and development
2019 Standout
Characterization of resistance to a potent d-peptide HIV entry inhibitor
2019
Bone morphogenetic proteins and their antagonists
2006
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
2022
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
2016
Repulsive Guidance Molecule (RGMa), a DRAGON Homologue, Is a Bone Morphogenetic Protein Co-receptor
2005
Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance
2007
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
Molecular profiling for precision cancer therapies
2020
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells
2019
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
2006
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
Anemia of Chronic Disease
2005 Standout
Hepatocellular carcinoma
2022 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Repulsive Guidance Molecule RGMa Alters Utilization of Bone Morphogenetic Protein (BMP) Type II Receptors by BMP2 and BMP4
2007
Signaling Receptors for TGF-β Family Members
2016
Competition radioimmunoassay for mason‐pfizer monkey virus: Comparison with recent isolates
1975
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Nucleotide sequence of Mason-Pfizer monkey virus: An immunosuppressive D-type retrovirus
1986
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Molecular and Biotechnological Aspects of Microbial Proteases
1998 Standout
Emerging Roles for the Transforming Growth Factor-β Superfamily in Regulating Adiposity and Energy Expenditure
2010
Detection of lymphocytes producing a human retrovirus associated with adult T-cell leukemia by syncytia induction assay.
1983
Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis
2010
Regression of Chemotherapy-Resistant Polymerase ϵ (POLE) Ultra-Mutated and MSH6 Hyper-Mutated Endometrial Tumors with Nivolumab
2016
Size matters: Dissecting key parameters for panel‐based tumor mutational burden analysis
2018
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
RGMa inhibition promotes axonal growth and recovery after spinal cord injury
2006
RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance
2014
An antagonistic role for theC. elegansSchnurri homolog SMA-9 in modulating TGFβ signaling during mesodermal patterning
2006 StandoutNobel
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
1984 StandoutNature
Tissue-Specific Immunoregulation: A Call for Better Understanding of the “Immunostat” in the Context of Cancer
2018
SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
2005 Standout
Nanoparticles: Augmenting Tumor Antigen Presentation for Vaccine and Immunotherapy Treatments of Cancer
2017
Radioimmunoassay for intact Gross mouse leukemia virus.
1976 StandoutNobel
Regulation of Iron Metabolism by Hepcidin
2006
Standardized and simplified nomenclature for proteins common to all retroviruses
1988 StandoutNobel
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Works of David Fabrizio being referenced
DRAGON, a Bone Morphogenetic Protein Co-receptor
2005
Reconstitution and Analysis of Soluble Inhibin and Activin Receptor Complexes in a Cell-free System
2004
DRAGON: A Member of the Repulsive Guidance Molecule-Related Family of Neuronal- and Muscle-Expressed Membrane Proteins Is Regulated by DRG11 and Has Neuronal Adhesive Properties
2004
Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies
2017
A Novel gp41-Binding Adnectin with Potent Anti-HIV Activity Is Highly Synergistic when Linked to a CD4-Binding Adnectin
2018
Biomarkers of immune checkpoint inhibitor response in metastatic breast cancer: PD-L1 protein expression, CD274 gene amplification, and total mutational burden.
2016
Hybrid capture-based next-generation sequencing (HC NGS) in melanoma to identify markers of response to anti-PD-1/PD-L1.
2016
Assessment and comparison of tumor mutational burden and microsatellite instability status in >40,000 cancer genomes
2016
Immunotherapy (IO) versus targeted therapy triage in endometrial adenocarcinoma (EA) by concurrent assessment of tumor mutation burden (TMB), microsatellite instability (MSI) status, and targetable genomic alterations (GA).
2016
Biologic Characteristics of Transformed Rhesus Foreskin Cells Infected With Mason-Pfizer Monkey Virus 2 3
1974
Prevalence ofPDL1Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors
2018
Total mutation burden (TMB) in lung cancer (LC) and relationship with response to PD-1/PD-L1 targeted therapies.
2016
Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma
2019
Association of high tissue TMB and atezolizumab efficacy across multiple tumor types.
2018
Tumor mutational burden as a potential biomarker for PD1/PD-L1 therapy in colorectal cancer.
2016
Assessment of tumor mutation burden from >60,000 clinical cancer patients using comprehensive genomic profiling.
2016
Blood-based biomarkers for cancer immunotherapy: Tumor mutational burden in blood (bTMB) is associated with improved atezolizumab (atezo) efficacy in 2L+ NSCLC (POPLAR and OAK)
2017